Yiteng Lu

State Key Laboratory Of Brain Function And Disorders
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A Receptor-Mediated Endolysosomal Recycling Chimera Enables Catalytic TNF-α Degradation for Sustained Treatment of Mucosal Inflammation.

A Receptor-Mediated Endolysosomal Recycling Chimera Enables Catalytic TNF-α Degradation for Sustained Treatment of Mucosal Inflammation.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: December 11, 2025

Sphingomyelin Synthase 2 Deletion Mitigates Oxidative Stress-Induced NF-κB Activation via Lipid Metabolic Reprogramming in Dry Eye Disease.

Sphingomyelin Synthase 2 Deletion Mitigates Oxidative Stress-Induced NF-κB Activation via Lipid Metabolic Reprogramming in Dry Eye Disease.

Journal: Investigative ophthalmology & visual science

Published: December 05, 2025

Somatostatin Ameliorates Corneal Nerve Abnormalities and Inflammation Through Regulation of Macrophage Activities in Dry Eye Disease.

Somatostatin Ameliorates Corneal Nerve Abnormalities and Inflammation Through Regulation of Macrophage Activities in Dry Eye Disease.

Journal: Investigative ophthalmology & visual science

Published: November 07, 2025

Dual-targeting fluorous peptide proteolysis-targeting chimeras for cancer therapy.

Dual-targeting fluorous peptide proteolysis-targeting chimeras for cancer therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 23, 2025

Itaconate derivative eye drops deploy anti-inflammatory effect in treating dry eye models.

Itaconate derivative eye drops deploy anti-inflammatory effect in treating dry eye models.

Journal: Advances in ophthalmology practice and research

Published: July 30, 2025

Identification of Matrix Metalloproteinase 3 as a Potential Biomarker for Dry Eye Disease.

Identification of Matrix Metalloproteinase 3 as a Potential Biomarker for Dry Eye Disease.

Journal: Translational vision science & technology

Published: July 28, 2025

Identification of a blink frequency threshold for maintaining tear film stability in young adults with dry eye symptoms.

Identification of a blink frequency threshold for maintaining tear film stability in young adults with dry eye symptoms.

Journal: Scientific reports

Published: March 02, 2025

A Supramolecular Deferoxamine-Crisaborole Nanoparticle Targets Ferroptosis, Inflammation, and Oxidative Stress in the Treatment of Retinal Ischemia/Reperfusion Injury.

A Supramolecular Deferoxamine-Crisaborole Nanoparticle Targets Ferroptosis, Inflammation, and Oxidative Stress in the Treatment of Retinal Ischemia/Reperfusion Injury.

Journal: Nano letters

Published: December 13, 2024

Topical delivery of a human single-domain antibody targeting IL-33 to inhibit mucosal inflammation.

Topical delivery of a human single-domain antibody targeting IL-33 to inhibit mucosal inflammation.

Journal: Cellular & molecular immunology

Published: August 26, 2024

Discovery of a novel thiophene carboxamide analogue as a highly potent and selective sphingomyelin synthase 2 inhibitor for dry eye disease therapy.

Discovery of a novel thiophene carboxamide analogue as a highly potent and selective sphingomyelin synthase 2 inhibitor for dry eye disease therapy.

Journal: Acta pharmaceutica Sinica. B

Published: June 12, 2024

Clinical characteristics of dry eye patients with thyroid disorders: a cross-sectional study.

Clinical characteristics of dry eye patients with thyroid disorders: a cross-sectional study.

Journal: BMC ophthalmology

Published: March 24, 2024

Inhibition of gasdermin D (GSDMD) as a promising therapeutic approach for atopic dermatitis.

Inhibition of gasdermin D (GSDMD) as a promising therapeutic approach for atopic dermatitis.

Journal: International immunopharmacology

Published: June 28, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026